CommercialCoverageMedium impact
08.02.06b, Tofersen (Qalsody®)
Independence Blue Cross·Neurology·Pharmacy
Effective date
Jul 23, 2025
We identified it
Jun 19, 2026
Summary
A policy for Tofersen (Qalsody®), a specialty pharmacy medication, has been reissued with updates effective July 23, 2025. This appears to be a commercial insurance policy update that may affect coverage, prior authorization, or billing requirements for this specific drug.
Action Required
By July 23, 2025: Review the complete policy details at the provided URL to understand specific changes to Tofersen (Qalsody®) coverage requirements. Update billing procedures, prior authorization workflows, and staff training as needed based on the full policy content.